ErgoPharm is a new division of the world's leading prohormone manufacturing and research company. In 1996, they pioneered the prohormone market through onsite manufacturing and stringent university testing.

They have launched every major product and innovation in the prohormone industry, including the first to release androstenedione, 4-androstenediol, and 19-norandrostenediol.

In addition, ErgoPharm is responsible for bringing innovative delivery systems to the prohormone market including HPB cyclodextrin, bioadhesive technology for sustained release, and sustained release sprays.